Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, January 17, 2020
[ Fri, Jan 17th 2020
] - WOPRAI
[ Fri, Jan 17th 2020
] - WOPRAI
[ Fri, Jan 17th 2020
] - WOPRAI
[ Fri, Jan 17th 2020
] - WOPRAI
[ Fri, Jan 17th 2020
] - WOPRAI
[ Fri, Jan 17th 2020
] - WOPRAI
[ Fri, Jan 17th 2020
] - WOPRAI
[ Fri, Jan 17th 2020
] - WOPRAI
[ Fri, Jan 17th 2020
] - WOPRAI
[ Fri, Jan 17th 2020
] - WOPRAI
[ Fri, Jan 17th 2020
] - WOPRAI
[ Fri, Jan 17th 2020
] - WOPRAI
[ Fri, Jan 17th 2020
] - WOPRAI
[ Fri, Jan 17th 2020
] - WOPRAI
[ Fri, Jan 17th 2020
] - WOPRAI
[ Fri, Jan 17th 2020
] - WOPRAI
[ Fri, Jan 17th 2020
] - WOPRAI
[ Fri, Jan 17th 2020
] - WOPRAI
[ Fri, Jan 17th 2020
] - WOPRAI
[ Fri, Jan 17th 2020
] - WOPRAI
[ Fri, Jan 17th 2020
] - WOPRAI
[ Fri, Jan 17th 2020
] - WOPRAI
[ Fri, Jan 17th 2020
] - WOPRAI
[ Fri, Jan 17th 2020
] - WOPRAI
[ Fri, Jan 17th 2020
] - WOPRAI
[ Fri, Jan 17th 2020
] - WOPRAI
[ Fri, Jan 17th 2020
] - WOPRAI
Matthew Harrison Initiated (BGNE) at Buy and Held Target at $210 on, Jan 17th, 2020
Matthew Harrison of Morgan Stanley, Initiated "BeiGene, Ltd." (BGNE) at Buy and Held Target at $210 on, Jan 17th, 2020.
Matthew has made no other calls on BGNE in the last 4 months.
There are 2 other peers that have a rating on BGNE. Out of the 2 peers that are also analyzing BGNE, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Tyler Van Buren of "Piper Sandler" Downgraded from Buy to Hold on, Monday, December 16th, 2019
This is the rating of the analyst that currently disagrees with Matthew
- Yaron Werber of "Cowen & Co." Maintained at Buy with Increased Target to $225 on, Wednesday, November 13th, 2019
